204 related articles for article (PubMed ID: 18287094)
1. Suppression of interferon (IFN)-inducible genes and IFN-mediated functional responses in BCR-ABL-expressing cells.
Katsoulidis E; Sassano A; Majchrzak-Kita B; Carayol N; Yoon P; Jordan A; Druker BJ; Fish EN; Platanias LC
J Biol Chem; 2008 Apr; 283(16):10793-803. PubMed ID: 18287094
[TBL] [Abstract][Full Text] [Related]
2. The p38 mitogen-activated protein kinase pathway and its role in interferon signaling.
Platanias LC
Pharmacol Ther; 2003 May; 98(2):129-42. PubMed ID: 12725866
[TBL] [Abstract][Full Text] [Related]
3. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.
Carlesso N; Frank DA; Griffin JD
J Exp Med; 1996 Mar; 183(3):811-20. PubMed ID: 8642285
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the transcriptional activity of the IRF7 promoter by a pathway independent of interferon signaling.
Ning S; Huye LE; Pagano JS
J Biol Chem; 2005 Apr; 280(13):12262-70. PubMed ID: 15664995
[TBL] [Abstract][Full Text] [Related]
5. Activation of mitogen-activated protein kinase kinase (MKK) 3 and MKK6 by type I interferons.
Li Y; Batra S; Sassano A; Majchrzak B; Levy DE; Gaestel M; Fish EN; Davis RJ; Platanias LC
J Biol Chem; 2005 Mar; 280(11):10001-10. PubMed ID: 15644321
[TBL] [Abstract][Full Text] [Related]
6. Kinase domain mutants of Bcr-Abl exhibit altered transformation potency, kinase activity, and substrate utilization, irrespective of sensitivity to imatinib.
Griswold IJ; MacPartlin M; Bumm T; Goss VL; O'Hare T; Lee KA; Corbin AS; Stoffregen EP; Smith C; Johnson K; Moseson EM; Wood LJ; Polakiewicz RD; Druker BJ; Deininger MW
Mol Cell Biol; 2006 Aug; 26(16):6082-93. PubMed ID: 16880519
[TBL] [Abstract][Full Text] [Related]
7. Activation of the p38 Map kinase pathway is essential for the antileukemic effects of dasatinib.
Dumka D; Puri P; Carayol N; Lumby C; Balachandran H; Schuster K; Verma AK; Terada LS; Platanias LC; Parmar S
Leuk Lymphoma; 2009 Dec; 50(12):2017-29. PubMed ID: 19672773
[TBL] [Abstract][Full Text] [Related]
8. Differential roles of STAT1 and STAT2 in the sensitivity of JAK2V617F- vs. BCR-ABL-positive cells to interferon alpha.
Schubert C; Allhoff M; Tillmann S; Maié T; Costa IG; Lipka DB; Schemionek M; Feldberg K; Baumeister J; Brümmendorf TH; Chatain N; Koschmieder S
J Hematol Oncol; 2019 Apr; 12(1):36. PubMed ID: 30940163
[TBL] [Abstract][Full Text] [Related]
9. Engagement of the CrkL adaptor in interferon alpha signalling in BCR-ABL-expressing cells.
Grumbach IM; Mayer IA; Uddin S; Lekmine F; Majchrzak B; Yamauchi H; Fujita S; Druker B; Fish EN; Platanias LC
Br J Haematol; 2001 Feb; 112(2):327-36. PubMed ID: 11167825
[TBL] [Abstract][Full Text] [Related]
10. Signal Integration of IFN-I and IFN-II With TLR4 Involves Sequential Recruitment of STAT1-Complexes and NFκB to Enhance Pro-inflammatory Transcription.
Piaszyk-Borychowska A; Széles L; Csermely A; Chiang HC; Wesoły J; Lee CK; Nagy L; Bluyssen HAR
Front Immunol; 2019; 10():1253. PubMed ID: 31231385
[TBL] [Abstract][Full Text] [Related]
11. BCR/abl leads to the constitutive activation of Stat proteins, and shares an epitope with tyrosine phosphorylated Stats.
Frank DA; Varticovski L
Leukemia; 1996 Nov; 10(11):1724-30. PubMed ID: 8892675
[TBL] [Abstract][Full Text] [Related]
12. Anthelmintic niclosamide suppresses transcription of BCR-ABL fusion oncogene via disabling Sp1 and induces apoptosis in imatinib-resistant CML cells harboring T315I mutant.
Jin B; Wang C; Shen Y; Pan J
Cell Death Dis; 2018 Jan; 9(2):68. PubMed ID: 29358661
[TBL] [Abstract][Full Text] [Related]
13. Time-dependent recruitment of GAF, ISGF3 and IRF1 complexes shapes IFNα and IFNγ-activated transcriptional responses and explains mechanistic and functional overlap.
Sekrecka A; Kluzek K; Sekrecki M; Boroujeni ME; Hassani S; Yamauchi S; Sada K; Wesoly J; Bluyssen HAR
Cell Mol Life Sci; 2023 Jun; 80(7):187. PubMed ID: 37347298
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML.
O'Hare T; Pollock R; Stoffregen EP; Keats JA; Abdullah OM; Moseson EM; Rivera VM; Tang H; Metcalf CA; Bohacek RS; Wang Y; Sundaramoorthi R; Shakespeare WC; Dalgarno D; Clackson T; Sawyer TK; Deininger MW; Druker BJ
Blood; 2004 Oct; 104(8):2532-9. PubMed ID: 15256422
[TBL] [Abstract][Full Text] [Related]
15. A requirement for SOCS-1 and SOCS-3 phosphorylation in Bcr-Abl-induced tumorigenesis.
Qiu X; Guo G; Chen K; Kashiwada M; Druker BJ; Rothman PB; Chen JL
Neoplasia; 2012 Jun; 14(6):547-58. PubMed ID: 22787435
[TBL] [Abstract][Full Text] [Related]
16. A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and Type II IFN Responses.
Michalska A; Blaszczyk K; Wesoly J; Bluyssen HAR
Front Immunol; 2018; 9():1135. PubMed ID: 29892288
[TBL] [Abstract][Full Text] [Related]
17. The p38 MAPK pathway mediates the growth inhibitory effects of interferon-alpha in BCR-ABL-expressing cells.
Mayer IA; Verma A; Grumbach IM; Uddin S; Lekmine F; Ravandi F; Majchrzak B; Fujita S; Fish EN; Platanias LC
J Biol Chem; 2001 Jul; 276(30):28570-7. PubMed ID: 11353767
[TBL] [Abstract][Full Text] [Related]
18. BCR-ABL induces opposite phenotypes in murine ES cells according to STAT3 activation levels.
Coppo P; Dusanter-Fourt I; Vainchenker W; Turhan AG
Cell Signal; 2009 Jan; 21(1):52-60. PubMed ID: 18835438
[TBL] [Abstract][Full Text] [Related]
19. Suppression of programmed cell death 4 (PDCD4) protein expression by BCR-ABL-regulated engagement of the mTOR/p70 S6 kinase pathway.
Carayol N; Katsoulidis E; Sassano A; Altman JK; Druker BJ; Platanias LC
J Biol Chem; 2008 Mar; 283(13):8601-10. PubMed ID: 18223253
[TBL] [Abstract][Full Text] [Related]
20. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]